Comments
Loading...
Amicus Therapeutics (FOLD) Forecast
NewsEarningsAmicus Therapeutics (FOLD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Amicus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:FOLD | Benzinga
Explore Amicus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FOLD.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Amicus Therapeutics (FOLD) stock?
You can purchase shares of Amicus Therapeutics (NASDAQ:FOLD) through any online brokerage.
Who are Amicus Therapeutics (FOLD) competitors?
Other companies in Amicus Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA) and Ascentage Pharma Group (NASDAQ:AAPG).
What is the forecast, or price target, for Amicus Therapeutics (FOLD) stock?
Amicus Therapeutics has a consensus price target of $16.33.
What is the current price for Amicus Therapeutics (FOLD)?
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $6.875 last updated April 15, 2025 at 1:33 PM EDT.
Does Amicus Therapeutics (FOLD) pay a dividend?
There are no upcoming dividends for Amicus Therapeutics.
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Amicus Therapeutics (FOLD) going to split?
There is no upcoming split for Amicus Therapeutics.
What sector and industry does Amicus Therapeutics (FOLD) operate in?
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.